Paul Hastings Advises Placement Agents in DBV Technologies’ Private Placement

Paul Hastings LLP advised LifeSci Capital LLC, Van Lanschot Kempen N.V. and Van Lanschot Kempen (USA) Inc. as placement agents in DBV Technologies’ (Nasdaq: DBVT) private placement, with a transaction value of up to $306.9 million. The investment will support DBV’s continued development of the Viaskin peanut patch for the treatment of pediatric peanut allergies.

Co-head of Equity Capital Markets and co-chair of the Corporate Life Sciences Group Seo Salimi and partner Will Magioncalda led the Paul Hastings team.

More details can be found here.

About Paul Hastings

With widely recognized elite teams across 17 core practices, Paul Hastings is a premier law firm with a culture of excellence focused on providing intellectual capital and superior execution globally to the world’s leading investment banks, asset managers and corporations.